# Saluda Medical Receives FDA Approval for CAP24 Surgical Paddle Lead for Chronic Pain

> fda · REPORTED · 2026-06-30

On June 30, 2026, Saluda Medical received FDA approval for its CAP24 paddle lead, the first spinal cord stimulation paddle lead purpose-built for closed-loop, ECAP-based neuromodulation, and completed first U.S. surgeries on July 16, 2026. The approval targets approximately 30% of U.S. SCS procedures performed by neurosurgeons and orthopedic surgeons, meaningfully expanding Saluda's addressable market.

About Saluda Medical: Saluda Medical is a commercial-stage medical device company that develops closed-loop spinal cord stimulation systems using its Evoke platform and EVA Sensing Technology to treat chronic pain and neurological conditions.

- Company: Saluda Medical
- Sector: neurotech
- Primary source: https://www.prnewswire.com/news-releases/saluda-medical-receives-us-fda-approval-for-new-cap24-surgical-paddle-lead-302814028.html

---
Source: MedFuel Intel news monitor. Verification tier: REPORTED. Informational only, not investment advice. Corrections: media@medfuelinc.com.